480
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

4-acetamido-3-nitrobenzoic acid - structural, quantum chemical studies, ADMET and molecular docking studies of SARS-CoV2

, , , , , , , , & show all
Pages 6656-6670 | Received 22 Sep 2020, Accepted 05 Feb 2021, Published online: 24 Feb 2021

References

  • Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
  • Dennington, R. D., Keith, T. A., & Millam, J. M. (2016). GaussView 6.0. 16.
  • Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A., & Puschmann, H. (2009). OLEX2: A complete structure solution, refinement and analysis program. Journal of Applied Crystallography, 42(2), 339–341. https://doi.org/10.1107/S0021889808042726
  • Fan, S., Xiao, D., Wang, Y., Liu, L., Zhou, X., & Zhong, W. (2020). Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2. Future Medicinal Chemistry, 12(17), 1565–1578. https://doi.org/10.4155/fmc-2020-0158
  • Fischer, A., Sellner, M., Neranjan, S., Smieško, M., & Lill, M. A. (2020). Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds. International Journal of Molecular Sciences, 21(10), 3626. https://doi.org/10.3390/ijms21103626
  • Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., & Li, X. (2016). Gaussian 16.
  • Harcourt, B. H., Jukneliene, D., Kanjanahaluethai, A., Bechill, J., Severson, K. M., Smith, C. M., Rota, P. A., & Baker, S. C. (2004). Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. Journal of Virology, 78(24), 13600–13612. https://doi.org/10.1128/JVI.78.24.13600-13612.2004
  • Hema, M. K., Karthik, C. S., Pampa, K. J., Manukumar, H. M., Mallu, P., Warad, I., & Lokanath, N. K. (2019). Solvent induced 4, 4, 4-trifluoro-1-(2-naphthyl)-1, 3-butanedione Cu (II) complexes: Synthesis, structure, DFT calculation and biocidal activity. Polyhedron, 168, 127–137. https://doi.org/10.1016/j.poly.2019.04.028
  • Krishnegowda, H. M., Karthik, C. S., Kudigana, P. J., Mallu, P., & Neratur, L. K. (2020). A μ-phenoxide bridged mixed ligand Cu (II) complex: Synthesis, 3D supramolecular architecture, DFT, energy frameworks and antimicrobial studies. Polyhedron, 185, 114571. https://doi.org/10.1016/j.poly.2020.114571
  • Kumar, A., Sharma, M., Chaubey, S. N., & Kumar, A. (2020). Homology modeling and molecular dynamics-based insights into Chalcone synthase and Chalcone isomerase in Phyllanthus emblica L. 3 Biotech, 10(8), 1–13. https://doi.org/10.1007/s13205-020-02367-2
  • Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M., & Wood, P. A. (2020). Mercury 4.0: From visualization to analysis, design and prediction. Journal of Applied Crystallography, 53(1), 226–235. https://doi.org/10.1107/S1600576719014092
  • Mahanta, S., Chowdhury, P., Gogoi, N., Goswami, N., Borah, D., Kumar, R., Chetia, D., Borah, P., Buragohain, A. K., & Gogoi, B. (2020). Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: An in silico-based approach. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–15. https://doi.org/10.1080/07391102.2020.1768902
  • Mirza, S. B., Salmas, R. E., Fatmi, M. Q., & Durdagi, S. (2016). Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study. Journal of Molecular Graphics & Modelling, 66, 99–107. https://doi.org/10.1016/j.jmgm.2016.03.008
  • Mohd Amin, S. N., Md Idris, M. H., Selvaraj, M., Mohd Amin, S. N., Jamari, H., Kek, T. L., & Salleh, M. Z. (2020). Virtual screening, ADME study, and molecular dynamic simulation of chalcone and flavone derivatives as 5-Lipoxygenase (5-LO) inhibitor. Molecular Simulation, 46(6), 487–496. https://doi.org/10.1080/08927022.2020.1732961
  • Pandey, P., Rane, J. S., Chatterjee, A., Kumar, A., Khan, R., Prakash, A., & Ray, S. (2020). Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: An in-silico study for drug development. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1796811
  • Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J Med Chem, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
  • Prajapat, M., Sarma, P., Shekhar, N., Avti, P., Sinha, S., Kaur, H., Kumar, S., Bhattacharyya, A., Kumar, H., Bansal, S., & Medhi, B. (2020). Drug targets for corona virus: A systematic review. Indian Journal of Pharmacology, 52(1), 56–65. https://doi.org/10.4103/ijp.IJP_115_20
  • Rigaku, C. C. S. (2011). Expert 2.0 r15. Software for Data Collection and Processing., Rigaku Corporation.
  • Romano, M., Ruggiero, A., Squeglia, F., Maga, G., & Berisio, R. (2020). A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. Cells, 9(5), 1267. https://doi.org/10.3390/cells9051267
  • Sahoo, C. R., Paidesetty, S. K., Dehury, B., & Padhy, R. N. (2020). Molecular dynamics and computational study of Mannich-based coumarin derivatives: Potent tyrosine kinase inhibitor. Journal of Biomolecular Structure & Dynamics, 38(18), 5419–5428. https://doi.org/10.1080/07391102.2019.1701554
  • Sheldrick, G. M. (1990). Phase annealing in SHELX-90: Direct methods for larger structures. Acta Crystallographica Section A Foundations of Crystallography, 46(6), 467–473. https://doi.org/10.1107/S0108767390000277
  • Sheldrick, G. M. (2015). Crystal structure refinement with SHELXL. Acta Crystallographica. Section C, Structural Chemistry, 71(Pt 1), 3–8. https://doi.org/10.1107/S2053229614024218
  • Spek, A. L. (1990). PLATON, an integrated tool for the analysis of the results of a single crystal structure determination. Acta Crystallogr. A, 46(s1), c34–c34.
  • Surti, M., Patel, M., Adnan, M., Moin, A., Ashraf, S. A., Siddiqui, A. J., Snoussi, M., Deshpande, S., & Reddy, M. N. (2020). Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: Designing, docking and molecular dynamics simulation study. RSC Advances, 10(62), 37707–37720. https://doi.org/10.1039/D0RA06379G
  • Thiel, V., Ivanov, K. A., Putics, Á., Hertzig, T., Schelle, B., Bayer, S., Weißbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., Gorbalenya, A. E., & Ziebuhr, J. (2003). Mechanisms and enzymes involved in SARS coronavirus genome expression. The Journal of General Virology, 84(Pt 9), 2305–2315. https://doi.org/10.1099/vir.0.19424-0
  • Vijayan, V., Pant, P., Vikram, N., Kaur, P., Singh, T. P., Sharma, S., & Sharma, P. (2020). Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/10.1080/07391102.2020.1802349
  • Wang, J. (2020). Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study. Journal of Chemical Information and Modeling, 60(6), 3277–3286. https://doi.org/10.1021/acs.jcim.0c00179
  • Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica. B, 10(5), 766–788. https://doi.org/10.1016/j.apsb.2020.02.008
  • Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020). Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 6(1), 14–18. https://doi.org/10.1038/s41421-020-0153-3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.